About Integer Holdings Corporation Common Stock (ITGR)
Integer Holdings Corp is a leading provider of advanced medical devices and components, specializing in the design and manufacture of innovative solutions for the healthcare industry. The company focuses on developing products that support critical therapeutic and diagnostic applications, catering to a diverse range of medical markets including cardiovascular, orthopedics, and neuromodulation. Integer's expertise encompasses a variety of technologies, enabling it to deliver high-quality, reliable medical products that enhance patient outcomes and drive advancements in healthcare. Through strategic partnerships and a commitment to innovation, Integer Holdings Corp plays a vital role in improving lives and expanding the possibilities of medical technology. Read More
Medical technology company Integer Holdings (NYSE:ITGR) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.4% year on year to $467.7 million. On the other hand, the company’s full-year revenue guidance of $1.85 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $1.79 per share was 6.8% above analysts’ consensus estimates.
New York, NY – October 23, 2025 – Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract manufacturer, experienced a dramatic downturn in its stock performance today, with shares plummeting a staggering 31.4%. The significant sell-off came despite the company reporting strong third-quarter 2025 earnings that largely met or exceeded
Shares of medical technology company Integer Holdings (NYSE:ITGR)
fell 31.4% in the afternoon session after the company reported third quarter earnings which revealed a significant reduction in its full-year profit forecast.
Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.
Medical technology company Integer Holdings (NYSE:ITGR) met Wall Street’s revenue expectations in Q3 CY2025, with sales up 8.4% year on year to $467.7 million. On the other hand, the company’s full-year revenue guidance of $1.85 billion at the midpoint came in 1% below analysts’ estimates. Its non-GAAP profit of $1.79 per share was 6.8% above analysts’ consensus estimates.
Medical technology company Integer Holdings (NYSE:ITGR)
will be reporting results this Thursday before market hours. Here’s what investors should know.
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.
Over the last six months, Integer Holdings’s shares have sunk to $103.40, producing a disappointing 9.2% loss - a stark contrast to the S&P 500’s 27.9% gain. This might have investors contemplating their next move.
Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q2 medical devices & supplies - specialty earnings season.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth.
This has capped the upside for healthcare stocks lately as the industry’s flat return over the past six months has trailed the S&P 500’s 15.9% gain.
A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
